The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...

Urgent class 1 recall affects thousands of Lay's Classic Potato Chips bags due to undeclared milk allergen, posing severe health risks to sensitive consumers.

House Republicans plan to introduce a bill that would officially designate several major Mexican drug cartels as foreign terrorist organizations (FTOs), legislation that would make President Donald ...

The U.S. Food and Drug Administration (FDA) has taken a crucial step to protect public health: it has banned the use of Red Dye No. 3 in all food products. This synthetic dye, known for giving a ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.

Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...

In today’s fast-paced world, weight loss can often feel like an uphill battle. With countless diets, exercise regimes, and ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...